• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021

    12/7/21 10:03:06 AM ET
    $APD
    $APPS
    $ARVN
    $AZN
    Major Chemicals
    Basic Materials
    Multi-Sector Companies
    Miscellaneous
    Get the next $APD alert in real time by email

     

    Upgrades

    • For CarMax Inc (NYSE:KMX), JP Morgan upgraded the previous rating of Neutral to Overweight. For the second quarter, CarMax had an EPS of $1.72, compared to year-ago quarter EPS of $1.79. The stock has a 52-week-high of $155.98 and a 52-week-low of $90.30. At the end of the last trading period, CarMax closed at $144.50.
    • According to Evercore ISI Group, the prior rating for RPM International Inc (NYSE:RPM) was changed from In-Line to Outperform. In the first quarter, RPM International showed an EPS of $1.08, compared to $1.44 from the year-ago quarter. The current stock performance of RPM International shows a 52-week-high of $99.30 and a 52-week-low of $76.43. Moreover, at the end of the last trading period, the closing price was at $95.43.
    • According to Evercore ISI Group, the prior rating for PPG Industries Inc (NYSE:PPG) was changed from In-Line to Outperform. In the third quarter, PPG Industries showed an EPS of $1.69, compared to $1.93 from the year-ago quarter. The stock has a 52-week-high of $182.97 and a 52-week-low of $132.10. At the end of the last trading period, PPG Industries closed at $164.43.
    • Evercore ISI Group upgraded the previous rating for Restaurant Brands International Inc (NYSE:QSR) from In-Line to Outperform. For the third quarter, Restaurant Brands Intl had an EPS of $0.76, compared to year-ago quarter EPS of $0.68. At the moment, the stock has a 52-week-high of $71.12 and a 52-week-low of $54.18. Restaurant Brands Intl closed at $57.54 at the end of the last trading period.
    • Macquarie upgraded the previous rating for Digital Turbine Inc (NASDAQ:APPS) from Neutral to Outperform. For the second quarter, Digital Turbine had an EPS of $0.44, compared to year-ago quarter EPS of $0.15. The stock has a 52-week-high of $102.56 and a 52-week-low of $39.40. At the end of the last trading period, Digital Turbine closed at $49.80.
    • For Global Blood Therapeutics Inc (NASDAQ:GBT), William Blair upgraded the previous rating of Market Perform to Outperform. For the third quarter, Global Blood Therapeutics had an EPS of $1.13, compared to year-ago quarter EPS of $0.97. At the moment, the stock has a 52-week-high of $52.49 and a 52-week-low of $25.11. Global Blood Therapeutics closed at $28.17 at the end of the last trading period.
    • MKM Partners upgraded the previous rating for Starbucks Corp (NASDAQ:SBUX) from Neutral to Buy. In the fourth quarter, Starbucks showed an EPS of $1.00, compared to $0.51 from the year-ago quarter. The current stock performance of Starbucks shows a 52-week-high of $126.32 and a 52-week-low of $95.92. Moreover, at the end of the last trading period, the closing price was at $113.36.
    • For Murphy Oil Corp (NYSE:MUR), JP Morgan upgraded the previous rating of Neutral to Overweight. For the third quarter, Murphy Oil had an EPS of $0.24, compared to year-ago quarter EPS of $0.15. The stock has a 52-week-high of $31.00 and a 52-week-low of $11.15. At the end of the last trading period, Murphy Oil closed at $27.41.
    • According to Raymond James, the prior rating for PLx Pharma Inc (NASDAQ:PLXP) was changed from Market Perform to Outperform. In the third quarter, PLx Pharma showed an EPS of $0.37, compared to $0.40 from the year-ago quarter. At the moment, the stock has a 52-week-high of $21.50 and a 52-week-low of $5.01. PLx Pharma closed at $8.21 at the end of the last trading period.
    • For Cerence Inc (NASDAQ:CRNC), Raymond James upgraded the previous rating of Market Perform to Outperform. For the fourth quarter, Cerence had an EPS of $0.66, compared to year-ago quarter EPS of $0.61. At the moment, the stock has a 52-week-high of $139.00 and a 52-week-low of $66.56. Cerence closed at $71.97 at the end of the last trading period.
    • According to Morgan Stanley, the prior rating for Patterson-UTI Energy Inc (NASDAQ:PTEN) was changed from Equal-Weight to Overweight. Patterson-UTI Energy earned $0.44 in the third quarter, compared to $0.60 in the year-ago quarter. At the moment, the stock has a 52-week-high of $11.27 and a 52-week-low of $4.89. Patterson-UTI Energy closed at $7.68 at the end of the last trading period.
    • JP Morgan upgraded the previous rating for Bumble Inc (NASDAQ:BMBL) from Neutral to Overweight. Bumble earned $0.06 in the third quarter, compared to $0.01 in the year-ago quarter. The stock has a 52-week-high of $84.80 and a 52-week-low of $30.10. At the end of the last trading period, Bumble closed at $33.25.
    • Jefferies upgraded the previous rating for CommScope Holding Co Inc (NASDAQ:COMM) from Hold to Buy. In the third quarter, CommScope Hldg Co showed an EPS of $0.29, compared to $0.51 from the year-ago quarter. The current stock performance of CommScope Hldg Co shows a 52-week-high of $22.18 and a 52-week-low of $9.25. Moreover, at the end of the last trading period, the closing price was at $10.22.
    • Jefferies upgraded the previous rating for Juniper Networks Inc (NYSE:JNPR) from Hold to Buy. For the third quarter, Juniper Networks had an EPS of $0.46, compared to year-ago quarter EPS of $0.43. At the moment, the stock has a 52-week-high of $33.02 and a 52-week-low of $21.40. Juniper Networks closed at $31.45 at the end of the last trading period.
    • For CVR Energy Inc (NYSE:CVI), Credit Suisse upgraded the previous rating of Underperform to Neutral. CVR Energy earned $0.24 in the third quarter, compared to $0.57 in the year-ago quarter. The current stock performance of CVR Energy shows a 52-week-high of $27.02 and a 52-week-low of $11.22. Moreover, at the end of the last trading period, the closing price was at $16.28.
    • For Jack In The Box Inc (NASDAQ:JACK), Deutsche Bank upgraded the previous rating of Hold to Buy. In the fourth quarter, Jack In The Box showed an EPS of $1.80, compared to $1.61 from the year-ago quarter. The stock has a 52-week-high of $124.53 and a 52-week-low of $77.13. At the end of the last trading period, Jack In The Box closed at $80.55.

    See all analyst ratings upgrades.

     

    Downgrades

    • Evercore ISI Group downgraded the previous rating for Air Products & Chemicals Inc (NYSE:APD) from Outperform to In-Line. For the fourth quarter, Air Products & Chemicals had an EPS of $2.51, compared to year-ago quarter EPS of $2.19. The current stock performance of Air Products & Chemicals shows a 52-week-high of $316.39 and a 52-week-low of $245.75. Moreover, at the end of the last trading period, the closing price was at $292.89.
    • For Merck & Co Inc (NYSE:MRK), Guggenheim downgraded the previous rating of Buy to Neutral. For the third quarter, Merck & Co had an EPS of $1.75, compared to year-ago quarter EPS of $1.74. The stock has a 52-week-high of $91.40 and a 52-week-low of $15.32. At the end of the last trading period, Merck & Co closed at $73.42.
    • For Del Taco Restaurants Inc (NASDAQ:TACO), Benchmark downgraded the previous rating of Buy to Hold. Del Taco Restaurants earned $0.11 in the third quarter, compared to $0.16 in the year-ago quarter. The stock has a 52-week-high of $12.54 and a 52-week-low of $7.34. At the end of the last trading period, Del Taco Restaurants closed at $12.51.
    • According to Raymond James, the prior rating for HealthEquity Inc (NASDAQ:HQY) was changed from Strong Buy to Outperform. For the third quarter, HealthEquity had an EPS of $0.35, compared to year-ago quarter EPS of $0.41. At the moment, the stock has a 52-week-high of $93.32 and a 52-week-low of $53.60. HealthEquity closed at $56.67 at the end of the last trading period.
    • According to Cowen & Co., the prior rating for Ross Stores Inc (NASDAQ:ROST) was changed from Outperform to Market Perform. In the third quarter, Ross Stores showed an EPS of $1.09, compared to $1.02 from the year-ago quarter. The stock has a 52-week-high of $134.22 and a 52-week-low of $104.79. At the end of the last trading period, Ross Stores closed at $112.68.
    • According to JP Morgan, the prior rating for CNX Resources Corp (NYSE:CNX) was changed from Overweight to Neutral. CNX Resources earned $0.74 in the third quarter, compared to $0.04 in the year-ago quarter. At the moment, the stock has a 52-week-high of $16.08 and a 52-week-low of $9.02. CNX Resources closed at $13.77 at the end of the last trading period.
    • JP Morgan downgraded the previous rating for Magnolia Oil & Gas Corp (NYSE:MGY) from Overweight to Neutral. For the third quarter, Magnolia Oil & Gas had an EPS of $0.67, compared to year-ago quarter EPS of $0.06. At the moment, the stock has a 52-week-high of $22.09 and a 52-week-low of $6.94. Magnolia Oil & Gas closed at $19.58 at the end of the last trading period.
    • For Del Taco Restaurants Inc (NASDAQ:TACO), Jefferies downgraded the previous rating of Buy to Hold. In the third quarter, Del Taco Restaurants showed an EPS of $0.11, compared to $0.16 from the year-ago quarter. At the moment, the stock has a 52-week-high of $12.54 and a 52-week-low of $7.34. Del Taco Restaurants closed at $12.51 at the end of the last trading period.
    • Morgan Stanley downgraded the previous rating for Helmerich & Payne Inc (NYSE:HP) from Equal-Weight to Underweight. Helmerich & Payne earned $0.62 in the fourth quarter, compared to $0.74 in the year-ago quarter. The stock has a 52-week-high of $36.26 and a 52-week-low of $20.93. At the end of the last trading period, Helmerich & Payne closed at $22.31.
    • For AstraZeneca PLC (NASDAQ:AZN), Jefferies downgraded the previous rating of Buy to Hold. AstraZeneca earned $0.54 in the third quarter, compared to $0.47 in the year-ago quarter. The current stock performance of AstraZeneca shows a 52-week-high of $64.21 and a 52-week-low of $46.48. Moreover, at the end of the last trading period, the closing price was at $55.41.

    See all analyst ratings downgrades.

     

    Initiations

    • With a Hold rating, CBRE initiated coverage on DraftKings Inc (NASDAQ:DKNG). The price target seems to have been set at $36.00 for DraftKings. DraftKings earned $1.35 in the third quarter, compared to $0.98 in the year-ago quarter. At the moment, the stock has a 52-week-high of $74.38 and a 52-week-low of $27.48. DraftKings closed at $30.68 at the end of the last trading period.
    • Aegis Capital initiated coverage on Chemomab Therapeutics Ltd (NASDAQ:CMMB) with a Buy rating. The price target for Chemomab Therapeutics is set to $30.00. For the third quarter, Chemomab Therapeutics had an EPS of $0.01, compared to year-ago quarter EPS of $0.01. The stock has a 52-week-high of $79.00 and a 52-week-low of $6.89. At the end of the last trading period, Chemomab Therapeutics closed at $7.43.
    • With a Neutral rating, UBS initiated coverage on Janus International Group Inc (NYSE:JBI). The price target seems to have been set at $14.00 for Janus Intl Gr. In the third quarter, Janus Intl Gr showed an EPS of $0.11, compared to $0.35 from the year-ago quarter. The stock has a 52-week-high of $15.94 and a 52-week-low of $11.60. At the end of the last trading period, Janus Intl Gr closed at $12.29.
    • Needham initiated coverage on DocGo Inc (NASDAQ:DCGO) with a Buy rating. The price target for DocGo is set to $14.00.
    • Jefferies initiated coverage on Vaxxinity Inc (NASDAQ:VAXX) with a Buy rating. The price target for Vaxxinity is set to $18.00.
    • Citigroup initiated coverage on Embark Technology Inc (NASDAQ:EMBK) with a Buy rating. The price target for Embark Technology is set to $11.00.
    • For Fate Therapeutics Inc (NASDAQ:FATE), Cowen & Co. initiated coverage, by setting the current rating at Outperform. Fate Therapeutics earned $0.45 in the third quarter, compared to $0.68 in the year-ago quarter. The current stock performance of Fate Therapeutics shows a 52-week-high of $121.16 and a 52-week-low of $44.99. Moreover, at the end of the last trading period, the closing price was at $47.84.
    • With an Outperform rating, Wolfe Research initiated coverage on XPO Logistics Inc (NYSE:XPO). The price target seems to have been set at $101.00 for XPO Logistics. XPO Logistics earned $0.94 in the third quarter, compared to $0.84 in the year-ago quarter. At the moment, the stock has a 52-week-high of $153.45 and a 52-week-low of $70.29. XPO Logistics closed at $75.48 at the end of the last trading period.
    • Wells Fargo initiated coverage on The Scotts Miracle Gro Co (NYSE:SMG) with an Overweight rating. The price target for Scotts Miracle Gro is set to $180.00. In the fourth quarter, Scotts Miracle Gro showed an EPS of $0.82, compared to $0.06 from the year-ago quarter. The current stock performance of Scotts Miracle Gro shows a 52-week-high of $254.34 and a 52-week-low of $133.36. Moreover, at the end of the last trading period, the closing price was at $138.82.
    • With a Hold rating, Stifel initiated coverage on Equity Residential (NYSE:EQR). The price target seems to have been set at $93.00 for Equity Residential. Equity Residential earned $0.77 in the third quarter, compared to $0.77 in the year-ago quarter. The current stock performance of Equity Residential shows a 52-week-high of $88.09 and a 52-week-low of $56.08. Moreover, at the end of the last trading period, the closing price was at $86.16.
    • Benchmark initiated coverage on Chart Industries Inc (NYSE:GTLS) with a Buy rating. The price target for Chart Industries is set to $206.00. In the third quarter, Chart Industries showed an EPS of $0.81, compared to $0.80 from the year-ago quarter. The stock has a 52-week-high of $206.29 and a 52-week-low of $103.77. At the end of the last trading period, Chart Industries closed at $166.42.
    • Baird initiated coverage on Fluence Energy Inc (NASDAQ:FLNC) with an Outperform rating. The price target for Fluence Energy is set to $44.00.
    • B. Riley Securities initiated coverage on Journey Medical Corp (NASDAQ:DERM) with a Buy rating. The price target for Journey Medical is set to $14.00. In the third quarter, Journey Medical showed an EPS of $1.06, compared to $1.58 from the year-ago quarter.
    • With an Outperform rating, Bernstein initiated coverage on CNH Industrial NV (NYSE:CNHI). The price target seems to have been set at $20.35 for CNH Industrial. In the third quarter, CNH Industrial showed an EPS of $0.36, compared to $0.11 from the year-ago quarter. The current stock performance of CNH Industrial shows a 52-week-high of $19.22 and a 52-week-low of $10.79. Moreover, at the end of the last trading period, the closing price was at $17.49.
    • JP Morgan initiated coverage on Columbus McKinnon Corp (NASDAQ:CMCO) with an Overweight rating. The price target for Columbus McKinnon is set to $64.00. For the second quarter, Columbus McKinnon had an EPS of $0.74, compared to year-ago quarter EPS of $0.34. At the moment, the stock has a 52-week-high of $57.06 and a 52-week-low of $37.34. Columbus McKinnon closed at $45.99 at the end of the last trading period.
    • With an Underweight rating, Wells Fargo initiated coverage on Canopy Growth Corp (NASDAQ:CGC). The price target seems to have been set at $8.00 for Canopy Gwth. In the second quarter, Canopy Gwth showed an EPS of $0.02, compared to $0.22 from the year-ago quarter. At the moment, the stock has a 52-week-high of $56.50 and a 52-week-low of $9.54. Canopy Gwth closed at $10.15 at the end of the last trading period.
    • Loop Capital initiated coverage on Zimmer Biomet Holdings Inc (NYSE:ZBH) with a Buy rating. The price target for Zimmer Biomet Holdings is set to $165.00. In the third quarter, Zimmer Biomet Holdings showed an EPS of $1.81, compared to $1.81 from the year-ago quarter. The stock has a 52-week-high of $180.36 and a 52-week-low of $119.55. At the end of the last trading period, Zimmer Biomet Holdings closed at $125.49.
    • Loop Capital initiated coverage on Stryker Corp (NYSE:SYK) with a Buy rating. The price target for Stryker is set to $305.00. In the third quarter, Stryker showed an EPS of $2.20, compared to $2.14 from the year-ago quarter. At the moment, the stock has a 52-week-high of $281.16 and a 52-week-low of $220.90. Stryker closed at $254.41 at the end of the last trading period.
    • Cowen & Co. initiated coverage on Moderna Inc (NASDAQ:MRNA) with a Market Perform rating. The price target for Moderna is set to $250.00. In the third quarter, Moderna showed an EPS of $7.70, compared to $0.59 from the year-ago quarter. The current stock performance of Moderna shows a 52-week-high of $497.49 and a 52-week-low of $102.66. Moreover, at the end of the last trading period, the closing price was at $265.33.
    • For CRISPR Therapeutics AG (NASDAQ:CRSP), Cowen & Co. initiated coverage, by setting the current rating at Market Perform. In the third quarter, CRISPR Therapeutics showed an EPS of $1.67, compared to $1.32 from the year-ago quarter. The stock has a 52-week-high of $220.20 and a 52-week-low of $67.15. At the end of the last trading period, CRISPR Therapeutics closed at $71.12.
    • For Turning Point Therapeutics Inc (NASDAQ:TPTX), Cowen & Co. initiated coverage, by setting the current rating at Outperform. For the third quarter, Turning Point had an EPS of $1.34, compared to year-ago quarter EPS of $0.42. At the moment, the stock has a 52-week-high of $141.30 and a 52-week-low of $34.58. Turning Point closed at $35.48 at the end of the last trading period.
    • Cowen & Co. initiated coverage on Arvinas Inc (NASDAQ:ARVN) with an Outperform rating. Arvinas earned $0.94 in the third quarter, compared to $0.79 in the year-ago quarter. The current stock performance of Arvinas shows a 52-week-high of $108.47 and a 52-week-low of $25.00. Moreover, at the end of the last trading period, the closing price was at $75.65.

    See all analyst ratings initiations.

    Get the next $APD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $APD
    $APPS
    $ARVN
    $AZN

    CompanyDatePrice TargetRatingAnalyst
    XPO Inc.
    $XPO
    2/11/2026$210.00Positive → Neutral
    Susquehanna
    Linde plc
    $LIN
    2/10/2026$460.00Buy → Hold
    DZ Bank
    Fluence Energy Inc.
    $FLNC
    2/10/2026$24.00Hold → Buy
    Jefferies
    Helmerich & Payne Inc.
    $HP
    2/9/2026$35.00 → $38.00Hold
    TD Cowen
    DraftKings Inc.
    $DKNG
    2/6/2026$41.00 → $32.00Outperform
    Bernstein
    Linde plc
    $LIN
    2/6/2026$455.00Overweight → Neutral
    Analyst
    Starbucks Corporation
    $SBUX
    1/30/2026$110.00 → $116.00Overweight
    Barclays
    Starbucks Corporation
    $SBUX
    1/30/2026$100.00 → $103.00Overweight
    Piper Sandler
    More analyst ratings

    $APD
    $APPS
    $ARVN
    $AZN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    XPO, Inc. downgraded by Susquehanna with a new price target

    Susquehanna downgraded XPO, Inc. from Positive to Neutral and set a new price target of $210.00

    2/11/26 7:51:34 AM ET
    $XPO
    Transportation Services
    Consumer Discretionary

    Linde plc downgraded by DZ Bank with a new price target

    DZ Bank downgraded Linde plc from Buy to Hold and set a new price target of $460.00

    2/10/26 7:59:52 AM ET
    $LIN
    Major Chemicals
    Basic Materials

    Fluence upgraded by Jefferies with a new price target

    Jefferies upgraded Fluence from Hold to Buy and set a new price target of $24.00

    2/10/26 7:57:53 AM ET
    $FLNC
    Industrial Machinery/Components
    Miscellaneous

    $APD
    $APPS
    $ARVN
    $AZN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer Dodge R Stanton converted options into 14,154 shares and covered exercise/tax liability with 6,193 shares, increasing direct ownership by 2% to 508,415 units (SEC Form 4)

    4 - DraftKings Inc. (0001883685) (Issuer)

    2/11/26 5:33:25 PM ET
    $DKNG
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Officer Liberman Paul converted options into 28,309 shares and covered exercise/tax liability with 8,663 shares, increasing direct ownership by 2% to 807,720 units (SEC Form 4)

    4 - DraftKings Inc. (0001883685) (Issuer)

    2/11/26 5:33:13 PM ET
    $DKNG
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Officer Kalish Matthew converted options into 28,309 shares and covered exercise/tax liability with 8,663 shares, increasing direct ownership by 0.34% to 5,793,109 units (SEC Form 4)

    4 - DraftKings Inc. (0001883685) (Issuer)

    2/11/26 5:33:18 PM ET
    $DKNG
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $APD
    $APPS
    $ARVN
    $AZN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    November 30, 2020 - Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Second COVID-19 Vaccine Candidate

    For Immediate Release: November 30, 2020 The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 17 to discuss the request for emergency use authorization (EUA) for a COVID-19 vaccine from Moderna, Inc. “In keeping with the FDA’s commitment to ensuring full transparency, dialogue and efficiency, the Vaccines and Related Biological Products Advisory Comm

    11/30/20 5:12:14 PM ET
    $MRNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $APD
    $APPS
    $ARVN
    $AZN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Patel Naimish bought $49,704 worth of shares (1,508 units at $32.96) (SEC Form 4)

    4 - CRISPR Therapeutics AG (0001674416) (Issuer)

    1/27/26 5:35:15 PM ET
    $CRSP
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Executive Officer Lamba Sanjiv bought $999,634 worth of Ordinary Shares (2,520 units at $396.68), increasing direct ownership by 3% to 90,794 units (SEC Form 4)

    4 - LINDE PLC (0001707925) (Issuer)

    12/8/25 3:26:43 PM ET
    $LIN
    Major Chemicals
    Basic Materials

    Co-Chief Executive Officer Ostrover Douglas I bought $2,379,469 worth of Class A Shares (158,000 units at $15.06) (SEC Form 4)

    4 - BLUE OWL CAPITAL INC. (0001823945) (Issuer)

    12/3/25 5:12:45 PM ET
    $OWL
    Investment Managers
    Finance

    $APD
    $APPS
    $ARVN
    $AZN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Arvinas Announces Appointment of Randy Teel, Ph.D., as President, Chief Executive Officer, and Director

    – Appointment of an experienced Arvinas executive with a proven ability to drive strategy and innovation positions the company for continued momentum and long-term growth – NEW HAVEN, Conn., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Arvinas, Inc. (NASDAQ:ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced the appointment of Randy Teel, Ph.D., as President and Chief Executive Officer (CEO), as well as a member of the Company's Board of Directors, effective today. Dr. Teel previously served as Arvinas' Chief Business Officer (CBO) and is recognized for his strategic leadership in advancing corporate growth and fostering

    2/12/26 7:00:00 AM ET
    $ARVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CarMax Names Keith Barr as Chief Executive Officer

    CarMax, Inc. (NYSE:KMX) ("CarMax" or the "Company") today announced that Keith Barr has been appointed President and Chief Executive Officer, and a member of the Board of Directors ("the Board"), effective March 16, 2026. David McCreight, current Interim President and CEO of CarMax, will transition to his prior duties as an independent Director of the Board. Tom Folliard will remain in his role as Interim Executive Chair of the Board until the Company's Annual Meeting in June 2026, after which he is expected to resume his prior duties as non-executive Chair of the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2026021283385

    2/12/26 6:50:00 AM ET
    $IHG
    $KMX
    Hotels/Resorts
    Consumer Discretionary
    Retail-Auto Dealers and Gas Stations

    Restaurant Brands International Inc. Reports Fourth Quarter and Full Year 2025 Results

    Consolidated system-wide sales grow 5.8% in the fourth quarter and 5.3% in 2025 Consolidated comparable sales up 3.1% in Q4, led by 6.1% at INTL, 2.8% at TH Canada and 2.6% at BK US Achieves 2025 targets for organic Adjusted Operating Income growth and net leverage Returns ~$1.1 billion of capital to shareholders in 2025 while investing for growth  MIAMI, Feb. 12, 2026 /CNW/ - Restaurant Brands International Inc. ("RBI") (NYSE:QSR) (TSX:QSR) (TSX:QSP) today reported financial results for the fourth quarter and full year ended December 31, 2025. Josh Kobza, Chief Executive Officer of RBI, commented, "Our performance in 2025 reflects the progress we've made strengthening our brands and our sys

    2/12/26 6:30:00 AM ET
    $QSR
    Restaurants
    Consumer Discretionary

    $APD
    $APPS
    $ARVN
    $AZN
    SEC Filings

    View All

    SEC Form 13F-NT filed by Jackson Financial Inc.

    13F-NT - Jackson Financial Inc. (0001822993) (Filer)

    2/12/26 7:45:07 AM ET
    $JXN
    Life Insurance
    Finance

    Arvinas Inc. filed SEC Form 8-K: Leadership Update

    8-K - ARVINAS, INC. (0001655759) (Filer)

    2/12/26 7:06:51 AM ET
    $ARVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CarMax Inc filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - CARMAX INC (0001170010) (Filer)

    2/12/26 6:53:31 AM ET
    $KMX
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    $APD
    $APPS
    $ARVN
    $AZN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by CVR Energy Inc.

    SC 13D/A - CVR ENERGY INC (0001376139) (Subject)

    1/7/25 6:12:47 AM ET
    $CVI
    Integrated oil Companies
    Energy

    Amendment: SEC Form SC 13D/A filed by ReNew Energy Global plc

    SC 13D/A - ReNew Energy Global plc (0001848763) (Subject)

    12/10/24 7:57:27 PM ET
    $RNW
    Electric Utilities: Central
    Utilities

    Amendment: SEC Form SC 13D/A filed by ReNew Energy Global plc

    SC 13D/A - ReNew Energy Global plc (0001848763) (Subject)

    12/10/24 7:53:40 PM ET
    $RNW
    Electric Utilities: Central
    Utilities

    $APD
    $APPS
    $ARVN
    $AZN
    Leadership Updates

    Live Leadership Updates

    View All

    CarMax Names Keith Barr as Chief Executive Officer

    CarMax, Inc. (NYSE:KMX) ("CarMax" or the "Company") today announced that Keith Barr has been appointed President and Chief Executive Officer, and a member of the Board of Directors ("the Board"), effective March 16, 2026. David McCreight, current Interim President and CEO of CarMax, will transition to his prior duties as an independent Director of the Board. Tom Folliard will remain in his role as Interim Executive Chair of the Board until the Company's Annual Meeting in June 2026, after which he is expected to resume his prior duties as non-executive Chair of the Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2026021283385

    2/12/26 6:50:00 AM ET
    $IHG
    $KMX
    Hotels/Resorts
    Consumer Discretionary
    Retail-Auto Dealers and Gas Stations

    Jack in the Box Inc. Reiterates Confidence in David Goebel-Led Board of Directors in Overseeing Successful Execution of "JACK on Track" Plan

    Highlights Biglari's Self-Interested Campaign and Contradictory and Volatile Behavior that Hindered the Board's Attempts at Constructive Engagement Urges Shareholders to Vote "FOR" all 10 of Jack in the Box's Director Nominees, including David Goebel, Independent Chair of the Jack in the Box Board, on the WHITE Proxy Card Visit www.KeepJackonTrack.com for More Information Jack in the Box Inc. ("Jack in the Box" or the "Company") (NASDAQ:JACK), today mailed a letter to shareholders in connection with its upcoming Annual Meeting of Shareholders scheduled to be held on February 27, 2026 (the "Annual Meeting"). Shareholders of record as of January 2, 2026, will be entitled to vote at the

    2/10/26 8:00:00 AM ET
    $JACK
    Restaurants
    Consumer Discretionary

    Pebblebrook Hotel Trust Elects Nina P. Jones and Bill Bayless to Board of Trustees

    The Company also announced the adoption of a New Principles-Based Board Refreshment Framework Pebblebrook Hotel Trust (NYSE:PEB) (the "Company" or "Pebblebrook") today announced the election of Nina P. Jones and Bill Bayless to the Board of Trustees. Ms. Jones's election is effective March 1, 2026. Mr. Bayless is expected to join the Board during the fourth quarter of 2026. Ms. Jones retired from T. Rowe Price, a global investment manager with over $1 trillion in assets under management, where she most recently served as Vice President, Portfolio Manager of the U.S. Real Estate Equity Strategy. She has more than 15 years of real estate investing experience at T. Rowe Price, also serving

    2/9/26 7:00:00 AM ET
    $EQR
    $PEB
    $SPG
    Real Estate Investment Trusts
    Real Estate

    $APD
    $APPS
    $ARVN
    $AZN
    Financials

    Live finance-specific insights

    View All

    Restaurant Brands International Inc. Reports Fourth Quarter and Full Year 2025 Results

    Consolidated system-wide sales grow 5.8% in the fourth quarter and 5.3% in 2025 Consolidated comparable sales up 3.1% in Q4, led by 6.1% at INTL, 2.8% at TH Canada and 2.6% at BK US Achieves 2025 targets for organic Adjusted Operating Income growth and net leverage Returns ~$1.1 billion of capital to shareholders in 2025 while investing for growth  MIAMI, Feb. 12, 2026 /CNW/ - Restaurant Brands International Inc. ("RBI") (NYSE:QSR) (TSX:QSR) (TSX:QSP) today reported financial results for the fourth quarter and full year ended December 31, 2025. Josh Kobza, Chief Executive Officer of RBI, commented, "Our performance in 2025 reflects the progress we've made strengthening our brands and our sys

    2/12/26 6:30:00 AM ET
    $QSR
    Restaurants
    Consumer Discretionary

    AstraZeneca results: FY and Q4 2025

    Strong commercial performance and excellent pipeline delivery in a continuing catalyst-rich period AstraZeneca: Revenue and EPS summary   FY 2025 % Change Q4 2025 % Change   $m Actual CER1 $m Actual CER - Product Sales 55,573 9 9 14,538 9 7 - Alliance Revenue 3,067 39 38 959 34 33 Product Revenue2 58,640 10 10 15,497 10 8 Collaboration Revenue 99 (89) (89) 6 (99) (99) Total Revenue 58,739 9 8 15,503 4

    2/10/26 7:00:00 AM ET
    $AZN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results

    Fourth quarter net sales of $2.244 billion increased 10.9% on a reported basis, 9.2% on a constant currency1 basis and 5.4% on an organic constant currency1 basisFourth quarter diluted earnings per share were $0.70, a decrease of 41.7%; adjusted1 diluted earnings per share were $2.42, an increase of 4.8%Full-year net sales of $8.232 billion increased 7.2% on a reported basis, 6.4% on a constant currency1 basis and 3.9% on an organic constant currency1 basisFull-year diluted earnings per share were $3.55, a decrease of 19.9%; adjusted1 diluted earnings per share were $8.20, an increase of 2.5%Company provides full-year 2026 financial guidanceWARSAW, Ind., Feb. 10, 2026 /PRNewswire/ -- Zimmer

    2/10/26 6:30:00 AM ET
    $ZBH
    Industrial Specialties
    Health Care